A Novel AAV8-Based Gene Therapy for Duchenne Muscular Dystrophy: Preclinical Studies in the Mdx Mouse

被引：0
|
作者：
Kim, SunJung [1 ]
Barton, Elisabeth R. [2 ]
Foltz, Steven [1 ]
Patel, Hiren [1 ]
Yang, Lin [1 ]
Kim, KwiHye [1 ]
Chan, Gary [1 ]
Qiao, Chunping [1 ]
Liu, Ye [1 ]
Fiscella, Michele [1 ]
Danos, Olivier [1 ]
Buss, Nick [1 ]
机构：
[1] REGENXBIO, Rockville, MD USA
[2] Univ Florida, Gainesville, FL USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1067
引用
收藏
页码：498 / 498
页数：1
相关论文
共 50 条
  • [41] Aberrant Respiratory Control in the Mdx Mouse Model of Duchenne Muscular Dystrophy
    Burns, David P.
    Lucking, Eric
    Roy, Arijit
    Murphy, Kevin
    McDonald, Fiona B.
    Wilson, Richard
    Edge, Deirdre
    O'Halloran, Ken D.
    FASEB JOURNAL, 2017, 31
  • [42] Sensorineural hearing loss in the mdx mouse: A model of Duchenne muscular dystrophy
    Raynor, EM
    Mulroy, MJ
    LARYNGOSCOPE, 1997, 107 (08): : 1053 - 1056
  • [43] PPMO pre-treatment is beneficial for AAV-based gene therapy in Duchenne muscular dystrophy
    Forand, A.
    Muchir, A.
    Mougenot, N.
    Sevoz-Couche, C.
    Peccate, C.
    Lemaitre, M.
    Wood, M.
    Lorain, S.
    Pietri-Rouxel, F.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S164 - S165
  • [44] The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy
    David W. Hammers
    Cora C. Hart
    Michael K. Matheny
    Lillian A. Wright
    Megan Armellini
    Elisabeth R. Barton
    H. Lee Sweeney
    Scientific Reports, 10
  • [45] The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy
    Hammers, David W.
    Hart, Cora C.
    Matheny, Michael K.
    Wright, Lillian A.
    Armellini, Megan
    Barton, Elisabeth R.
    Sweeney, H. Lee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] Development of gene therapy for Duchenne muscular dystrophy using systemic delivery of AAV vectors
    Chamberlain, J. S.
    Gregorevic, P.
    Schultz, B.
    Odom, G.
    Finn, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S124 - S124
  • [47] AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial
    Mendell, Jerry R.
    Muntoni, Francesco
    Mcdonald, Craig M.
    Mercuri, Eugenio M.
    Ciafaloni, Emma
    Komaki, Hirofumi
    Leon-Astudillo, Carmen
    Nascimento, Andres
    Proud, Crystal
    Schara-Schmidt, Ulrike
    Veerapandiyan, Aravindhan
    Zaidman, Craig M.
    Guridi, Maitea
    Murphy, Alexander P.
    Reid, Carol
    Wandel, Christoph
    Asher, Damon R.
    Darton, Eddie
    Mason, Stefanie
    Potter, Rachael A.
    Singh, Teji
    Zhang, Wenfei
    Fontoura, Paulo
    Elkins, Jacob S.
    Rodino-Klapac, Louise R.
    NATURE MEDICINE, 2025, 31 (01) : 332 - 341
  • [48] Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular Dystrophy
    Hori, Yusuke S.
    Kuno, Atsushi
    Hosoda, Ryusuke
    Tanno, Masaya
    Miura, Tetsuji
    Shimamoto, Kazuaki
    Horio, Yoshiyuki
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (03): : 784 - 794
  • [49] COMBINATORIAL GENE THERAPY USING AAV VECTOR TECHNOLOGY TO TREAT DUCHENNE MUSCULAR DYSTROPHY
    Colgan, T. D.
    Murphy, K. T.
    Lynch, G. S.
    Gregorevic, P.
    JOURNAL OF GENE MEDICINE, 2013, 15 (8-9): : 325 - 326
  • [50] AAV PGC1-Alpha Gene Therapy Improves the Cardiac Function in a Mouse Model of Duchenne Muscular Dystrophy
    Wasala, Lakmini
    Wasala, Nalinda
    Zhao, Junling
    Yue, Yongping
    Lai, Yi
    Duan, Dongsheng
    MOLECULAR THERAPY, 2020, 28 (04) : 220 - 220
12345